126 related articles for article (PubMed ID: 35579910)
1. Preparation of a novel tacrolimus ion sensitive ocular in situ gel and
Sun J; Sun X
Pharm Dev Technol; 2022 Apr; 27(4):399-405. PubMed ID: 35579910
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Characterization of Tacrolimus-Loaded SLNs in situ Gel for Ocular Drug Delivery for the Treatment of Immune Conjunctivitis.
Sun K; Hu K
Drug Des Devel Ther; 2021; 15():141-150. PubMed ID: 33469266
[TBL] [Abstract][Full Text] [Related]
3. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis.
Shen T; Yang Z
Drug Des Devel Ther; 2021; 15():2099-2107. PubMed ID: 34040348
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis.
Saher O; Ghorab DM; Mursi NM
Pharm Dev Technol; 2016 Aug; 21(5):600-10. PubMed ID: 25886078
[TBL] [Abstract][Full Text] [Related]
7. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin Hemihydrate In Situ Gelling Ophthalmic Solution: Formulation Optimization and In Vitro and In Vivo Evaluation.
Bhalerao H; Koteshwara KB; Chandran S
AAPS PharmSciTech; 2019 Aug; 20(7):272. PubMed ID: 31372767
[TBL] [Abstract][Full Text] [Related]
9. Preparation of levofloxacin loaded
Jain P; Jaiswal CP; Mirza MA; Anwer MK; Iqbal Z
Drug Dev Ind Pharm; 2020 Jan; 46(1):50-56. PubMed ID: 31818154
[TBL] [Abstract][Full Text] [Related]
10. In vitro-in vivo evaluation of tetrahydrozoline-loaded ocular in situ gels on rabbits for allergic conjunctivitis management.
Okur NÜ; Yozgatli V; Okur ME
Drug Dev Res; 2020 Sep; 81(6):716-727. PubMed ID: 32359095
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
Rupenthal ID; Green CR; Alany RG
Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
Khan N; Aqil M; Imam SS; Ali A
Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
[TBL] [Abstract][Full Text] [Related]
13. A polymeric aqueous tacrolimus formulation for topical ocular delivery.
Badr MY; Abdulrahman NS; Schatzlein AG; Uchegbu IF
Int J Pharm; 2021 Apr; 599():120364. PubMed ID: 33571621
[TBL] [Abstract][Full Text] [Related]
14. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
[TBL] [Abstract][Full Text] [Related]
15. In situ gelling formulation based on methylcellulose/pectin system for oral-sustained drug delivery to dysphagic patients.
Itoh K; Hatakeyama T; Shimoyama T; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2011 Jul; 37(7):790-7. PubMed ID: 21405940
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of bear bile-loaded pH sensitive
Ni X; Guo Q; Zou Y; Xuan Y; Mohammad IS; Ding Q; Hu H
Iran J Basic Med Sci; 2020 Jul; 23(7):922-929. PubMed ID: 32774815
[TBL] [Abstract][Full Text] [Related]
17. Formulation development, optimization, and in vitro assessment of thermoresponsive ophthalmic pluronic F127-chitosan
Modi D; Mohammad ; Warsi MH; Garg V; Bhatia M; Kesharwani P; Jain GK
J Biomater Sci Polym Ed; 2021 Sep; 32(13):1678-1702. PubMed ID: 34013840
[TBL] [Abstract][Full Text] [Related]
18. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
Galgatte UC; Kumbhar AB; Chaudhari PD
Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
[TBL] [Abstract][Full Text] [Related]
19. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
[TBL] [Abstract][Full Text] [Related]
20. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Sreeharsha N; Morsy MA; Gupta S; Attimarad M; Shinu P; Venugopala KN
PLoS One; 2021; 16(3):e0248857. PubMed ID: 33739996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
